Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05129384 · ClinicalTrials.gov registry record · NA
The COLIC Study: Colonization of the Infant Gut With B. Infantis EVC001 to Reduce Symptoms of Colic
A NA study, sponsored by Evolve BioSystems.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05129384 is a NA study that was terminated before completion, run by Evolve BioSystems. The registered enrollment target is 1 participants.
The verdict
NCT05129384, a NA study, was terminated before completion, sponsored by Evolve BioSystems.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To investigate whether B. infantis EVC001 colonization in the infant gut can reduce symptoms of colic
Interventions
- DIETARY_SUPPLEMENT B. infantis EVC001 or Lactose Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-02-23 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05129384
The ClinicalTrials.gov registry entry for NCT05129384 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Evolve BioSystems, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which B. infantis EVC001 or Lactose Placebo is the first listed.
NCT05129384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05129384 about?
NCT05129384 is a clinical study titled "The COLIC Study: Colonization of the Infant Gut With B. Infantis EVC001 to Reduce Symptoms of Colic". To investigate whether B. infantis EVC001 colonization in the infant gut can reduce symptoms of colic
What is the current status of trial NCT05129384?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2022-02-23. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT05129384?
The interventions under investigation include: B. infantis EVC001 or Lactose Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05129384?
This trial is sponsored by Evolve BioSystems, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.